TaggScreening-detected positive serology for celiac disease: is there always mucosal damage?

Affiliations

¹ Department of Pathology and Laboratory Medicine, University of California Los Angeles (UCLA), Technology Center for Genomics and Bioinformatics, Los Angeles, California, USA.

Linda Beenet. Eur J Gastroenterol Hepatol. 2021.

. 2021 Nov 1;33(11):1463-1464.

doi: 10.1097/MEG.0000000000002213.

¹ Department of Pathology and Laboratory Medicine, University of California Los Angeles (UCLA), Technology Center for Genomics and Bioinformatics, Los Angeles, California, USA.

No abstract available

Comment in

Response to Screening-detected positive serology for celiac disease: is there always mucosal damage?
Donat E, Roca M, Masip E, Polo B, Ramos D, Ribes-Koninckx C. Donat E, et al. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e1109. doi: 10.1097/MEG.0000000000002228. Eur J Gastroenterol Hepatol. 2021. PMID: 35048685 No abstract available.

1. Donat E, Roca M, Masip E, Polo B, Ramos D, Ribes-Koninckx C. Screening-detected positive serology for celiac disease: a real clinical challenge. [published online ahead of print April 19, 2021]. Eur J Gastroenterol Hepatol.
1. Granito A, Muratori L, Muratori P, Petrolini N, Bianchi FB, Volta U. Antitransglutaminase antibodies and giardiasis. Am J Gastroenterol 2004; 99:2505–2506.
1. Lock RJ, Stevens S, Pitcher MC, Unsworth DJ. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease? Eur J Gastroenterol Hepatol 2004; 16:467–470.
1. Johnston SD, McMillan SA, Collins JS, Tham TC, McDougall NI, Murphy P. A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 2003; 15:1001–1004.
1. Granito A, Muratori P, Cassani F, Pappas G, Muratori L, Agostinelli D, et al. Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol 2004; 137:386–392.